US Broker Ratings

Orthofix Medical Inc. (OFIX) Stock Analysis: A Look at 40.74% Potential Upside in the Medical Device Sector

Orthofix Medical Inc. (NASDAQ: OFIX) is capturing investor attention with its promising 40.74% potential upside, as suggested by current analyst ratings. For those exploring opportunities in..

Tilray Brands, Inc. (TLRY) Stock Analysis: Exploring a 77% Potential Upside and Current Market Position

Tilray Brands, Inc. (NASDAQ: TLRY), a key player in the healthcare sector, is making waves in the specialty and generic drug manufacturing industry. Headquartered in Leamington,..

Celcuity Inc. (CELC) Investor Outlook: Analyzing the Biotechnology Stock with a $4.84 Billion Market Cap

Celcuity Inc. (NASDAQ: CELC) presents an intriguing opportunity for investors delving into the healthcare sector, particularly within biotechnology. With a remarkable market capitalization of $4.84 billion,..

Precigen, Inc. (PGEN) Stock Analysis: Biotechnology Innovator with Potential 84% Upside

Precigen, Inc. (NASDAQ: PGEN) is capturing the attention of investors with its cutting-edge advancements in gene and cell therapies. As a discovery and clinical-stage biopharmaceutical company,..

Ginkgo Bioworks Holdings, Inc. (DNA) Stock Analysis: Navigating the Biotech Terrain with a 10.38% Upside Potential

For investors considering a foray into the biotechnology sector, Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) presents a compelling case with its unique cell programming platform. Despite..

Definitive Healthcare Corp. (DH) Stock Analysis: Uncovering a 50% Potential Upside with Healthcare SaaS

Definitive Healthcare Corp. (NASDAQ: DH) operates at the intersection of healthcare and technology, offering a SaaS-based healthcare commercial intelligence platform. Despite facing challenges in the past..

Collegium Pharmaceutical (COLL) Stock Analysis: A Healthcare Innovator with a Strong Upside Potential

Collegium Pharmaceutical, Inc. (NASDAQ: COLL) stands out in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With a firm focus on developing..

Treace Medical Concepts, Inc. (TMCI) Stock Analysis: Is a 64% Upside Within Reach?

Investors keeping an eye on the healthcare sector should take note of Treace Medical Concepts, Inc. (TMCI), a promising player in the medical devices industry with..

MBX Biosciences, Inc. (MBX) Investor Outlook: Exploring a 93% Potential Upside in Precision Peptide Therapies

MBX Biosciences, Inc. (MBX), a dynamic player in the biotechnology sector, has been capturing investor attention with its pioneering work in precision peptide therapies aimed at..

Akso Health Group (AHG) Investor Outlook: High Revenue Growth Amid Uncertain Valuation

Akso Health Group (NASDAQ: AHG) is capturing attention in the healthcare sector with a remarkable revenue growth rate of 415.80%. Operating primarily in medical distribution, the..

Organogenesis Holdings Inc. (ORGO) Stock Analysis: Exploring a 101.90% Potential Upside in the Regenerative Medicine Market

For investors with a keen interest in the healthcare sector, Organogenesis Holdings Inc. (NASDAQ: ORGO) presents a compelling opportunity. With a focus on regenerative medicine, Organogenesis..

Cel-Sci Corporation (CVM) Investor Outlook: Exploring a Potential 625% Upside

Investors intrigued by the dynamic world of biotechnology are turning their attention to Cel-Sci Corporation (NASDAQ: CVM), a clinical-stage biotech firm with a focus on harnessing..

Niagen Bioscience, Inc. (NAGE) Stock Analysis: 140.85% Upside Potential Captures Investor Attention

Niagen Bioscience, Inc. (NAGE), a burgeoning entity in the biotechnology industry, is currently drawing significant attention from investors due to its impressive growth potential and market..

Maravai LifeSciences Holdings (MRVI) Stock Analysis: An Investor’s Guide to Navigating the Biotech Sector

Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) has been making headlines in the biotechnology sector, a space characterized by rapid innovation and significant investment opportunities. With a..

Evolus, Inc. (EOLS) Stock Analysis: Unpacking a 222% Potential Upside in the Aesthetic Market

For those with an eye on the healthcare sector, Evolus, Inc. (NASDAQ: EOLS) presents an intriguing investment opportunity. With a market capitalization of $372.07 million and..

Relay Therapeutics, Inc. (RLAY) Stock Analysis: 82.5% Potential Upside in Precision Medicine

Investors with an eye on the healthcare sector might find Relay Therapeutics, Inc. (NASDAQ: RLAY) an intriguing opportunity, particularly given its potential upside of 82.5%. This..

Inventiva S.A. (IVA): Biotechnology Innovator with Over 200% Potential Upside

Inventiva S.A. (IVA), a trailblazer in the healthcare sector, is captivating investor attention with its compelling growth trajectory and significant market potential. Headquartered in Daix, France,..

Akebia Therapeutics, Inc. (AKBA) Stock Analysis: Unveiling a Potential 262% Upside for Healthcare Investors

Akebia Therapeutics, Inc. (AKBA), a key player in the healthcare sector, particularly in the specialty and generic drug manufacturing industry, is drawing significant investor attention with..

Xeris Biopharma Holdings (XERS): Growth Potential and Analyst Consensus Highlight a 37% Upside

Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) is drawing significant attention in the biotechnology sector, with a market cap of $1.35 billion and a strong focus on..

Community Health Systems, Inc. (CYH) Stock Report: An Investor’s Guide to Potential Upside with a 10.23% Forecast

Community Health Systems, Inc. (NYSE: CYH), a prominent player in the healthcare sector, operates a network of general acute care hospitals across the United States. With..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds